528 related articles for article (PubMed ID: 34176681)
1. Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set.
Klein EA; Richards D; Cohn A; Tummala M; Lapham R; Cosgrove D; Chung G; Clement J; Gao J; Hunkapiller N; Jamshidi A; Kurtzman KN; Seiden MV; Swanton C; Liu MC
Ann Oncol; 2021 Sep; 32(9):1167-1177. PubMed ID: 34176681
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of cell-free DNA approaches for multi-cancer early detection.
Jamshidi A; Liu MC; Klein EA; Venn O; Hubbell E; Beausang JF; Gross S; Melton C; Fields AP; Liu Q; Zhang N; Fung ET; Kurtzman KN; Amini H; Betts C; Civello D; Freese P; Calef R; Davydov K; Fayzullina S; Hou C; Jiang R; Jung B; Tang S; Demas V; Newman J; Sakarya O; Scott E; Shenoy A; Shojaee S; Steffen KK; Nicula V; Chien TC; Bagaria S; Hunkapiller N; Desai M; Dong Z; Richards DA; Yeatman TJ; Cohn AL; Thiel DD; Berry DA; Tummala MK; McIntyre K; Sekeres MA; Bryce A; Aravanis AM; Seiden MV; Swanton C
Cancer Cell; 2022 Dec; 40(12):1537-1549.e12. PubMed ID: 36400018
[TBL] [Abstract][Full Text] [Related]
3. Performance of a targeted methylation-based multi-cancer early detection test by race and ethnicity.
Tang WHW; Yimer H; Tummala M; Shao S; Chung G; Clement J; Chu BC; Hubbell E; Kurtzman KN; Swanton C; Roberts LR
Prev Med; 2023 Feb; 167():107384. PubMed ID: 36495927
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Significance of Blood-Based Multi-cancer Detection in Plasma Cell-Free DNA.
Chen X; Dong Z; Hubbell E; Kurtzman KN; Oxnard GR; Venn O; Melton C; Clarke CA; Shaknovich R; Ma T; Meixiong G; Seiden MV; Klein EA; Fung ET; Liu MC
Clin Cancer Res; 2021 Aug; 27(15):4221-4229. PubMed ID: 34088722
[TBL] [Abstract][Full Text] [Related]
5. Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA.
Liu MC; Oxnard GR; Klein EA; Swanton C; Seiden MV;
Ann Oncol; 2020 Jun; 31(6):745-759. PubMed ID: 33506766
[TBL] [Abstract][Full Text] [Related]
6. Unintrusive multi-cancer detection by circulating cell-free DNA methylation sequencing (THUNDER): development and independent validation studies.
Gao Q; Lin YP; Li BS; Wang GQ; Dong LQ; Shen BY; Lou WH; Wu WC; Ge D; Zhu QL; Xu Y; Xu JM; Chang WJ; Lan P; Zhou PH; He MJ; Qiao GB; Chuai SK; Zang RY; Shi TY; Tan LJ; Yin J; Zeng Q; Su XF; Wang ZD; Zhao XQ; Nian WQ; Zhang S; Zhou J; Cai SL; Zhang ZH; Fan J
Ann Oncol; 2023 May; 34(5):486-495. PubMed ID: 36849097
[TBL] [Abstract][Full Text] [Related]
7. Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort study.
Nicholson BD; Oke J; Virdee PS; Harris DA; O'Doherty C; Park JE; Hamady Z; Sehgal V; Millar A; Medley L; Tonner S; Vargova M; Engonidou L; Riahi K; Luan Y; Hiom S; Kumar H; Nandani H; Kurtzman KN; Yu LM; Freestone C; Pearson S; Hobbs FR; Perera R; Middleton MR
Lancet Oncol; 2023 Jul; 24(7):733-743. PubMed ID: 37352875
[TBL] [Abstract][Full Text] [Related]
8. Performance of a Cell-Free DNA-Based Multi-cancer Detection Test in Individuals Presenting With Symptoms Suspicious for Cancers.
Bryce AH; Thiel DD; Seiden MV; Richards D; Luan Y; Coignet M; Zhang Q; Zhang N; Hubbell E; Kurtzman KN; Klein EA
JCO Precis Oncol; 2023 Jul; 7():e2200679. PubMed ID: 37467458
[TBL] [Abstract][Full Text] [Related]
9. Prediction of methylation status using WGS data of plasma cfDNA for multi-cancer early detection (MCED).
Cui P; Zhou X; Xu S; He W; Huang G; Xiong Y; Zhang C; Chang T; Feng M; Lai H; Pan Y
Clin Epigenetics; 2024 Feb; 16(1):34. PubMed ID: 38414068
[TBL] [Abstract][Full Text] [Related]
10. The Potential Value-Based Price of a Multi-Cancer Early Detection Genomic Blood Test to Complement Current Single Cancer Screening in the USA.
Tafazzoli A; Ramsey SD; Shaul A; Chavan A; Ye W; Kansal AR; Ofman J; Fendrick AM
Pharmacoeconomics; 2022 Nov; 40(11):1107-1117. PubMed ID: 36038710
[TBL] [Abstract][Full Text] [Related]
11. Circulating cell-free DNA-based multi-cancer early detection.
Zhang K; Fu R; Liu R; Su Z
Trends Cancer; 2024 Feb; 10(2):161-174. PubMed ID: 37709615
[TBL] [Abstract][Full Text] [Related]
12. Patient Preferences for Multi-Cancer Early Detection (MCED) Screening Tests.
Gelhorn H; Ross MM; Kansal AR; Fung ET; Seiden MV; Krucien N; Chung KC
Patient; 2023 Jan; 16(1):43-56. PubMed ID: 35844011
[TBL] [Abstract][Full Text] [Related]
13. Estimating the population health impact of a multi-cancer early detection genomic blood test to complement existing screening in the US and UK.
Hackshaw A; Cohen SS; Reichert H; Kansal AR; Chung KC; Ofman JJ
Br J Cancer; 2021 Nov; 125(10):1432-1442. PubMed ID: 34426664
[TBL] [Abstract][Full Text] [Related]
14. Analytical validation of a multi-cancer early detection test with cancer signal origin using a cell-free DNA-based targeted methylation assay.
Alexander GE; Lin W; Ortega FE; Ramaiah M; Jung B; Ji L; Revenkova E; Shah P; Croisetiere C; Berman JR; Eubank L; Naik G; Brooks J; Mich A; Shojaee S; Ronaghi N; Chawla H; Hou X; Liu Q; Yakym CAV; Moradi PW; Halks-Miller M; Aravanis AM; Parpart-Li S; Hunkapiller N
PLoS One; 2023; 18(4):e0283001. PubMed ID: 37058491
[TBL] [Abstract][Full Text] [Related]
15. Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort study.
Schrag D; Beer TM; McDonnell CH; Nadauld L; Dilaveri CA; Reid R; Marinac CR; Chung KC; Lopatin M; Fung ET; Klein EA
Lancet; 2023 Oct; 402(10409):1251-1260. PubMed ID: 37805216
[TBL] [Abstract][Full Text] [Related]
16. How to detect cancer early using cell-free DNA.
Hasenleithner SO; Speicher MR
Cancer Cell; 2022 Dec; 40(12):1464-1466. PubMed ID: 36513047
[TBL] [Abstract][Full Text] [Related]
17. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
[TBL] [Abstract][Full Text] [Related]
18. A panel of seven protein tumour markers for effective and affordable multi-cancer early detection by artificial intelligence: a large-scale and multicentre case-control study.
Luan Y; Zhong G; Li S; Wu W; Liu X; Zhu D; Feng Y; Zhang Y; Duan C; Mao M
EClinicalMedicine; 2023 Jul; 61():102041. PubMed ID: 37387788
[TBL] [Abstract][Full Text] [Related]
19. Multi-cancer early detection test sensitivity for cancers with and without current population-level screening options.
Shao SH; Allen B; Clement J; Chung G; Gao J; Hubbell E; Liu MC; Swanton C; Tang WHW; Yimer H; Tummala M
Tumori; 2023 Jun; 109(3):335-341. PubMed ID: 36316952
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive detection of any-stage cancer using free glycosaminoglycans.
Bratulic S; Limeta A; Dabestani S; Birgisson H; Enblad G; Stålberg K; Hesselager G; Häggman M; Höglund M; Simonson OE; Stålberg P; Lindman H; Bång-Rudenstam A; Ekstrand M; Kumar G; Cavarretta I; Alfano M; Pellegrino F; Mandel-Clausen T; Salanti A; Maccari F; Galeotti F; Volpi N; Daugaard M; Belting M; Lundstam S; Stierner U; Nyman J; Bergman B; Edqvist PH; Levin M; Salonia A; Kjölhede H; Jonasch E; Nielsen J; Gatto F
Proc Natl Acad Sci U S A; 2022 Dec; 119(50):e2115328119. PubMed ID: 36469776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
